These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 10448105

  • 1. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D, Bisogno T, De Petrocellis L, Chuang H, Julius D, Bifulco M, Di Marzo V.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):275-84. PubMed ID: 10448105
    [Abstract] [Full Text] [Related]

  • 2. A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.
    Di Marzo V, Griffin G, De Petrocellis L, Brandi I, Bisogno T, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR.
    J Pharmacol Exp Ther; 2002 Mar 19; 300(3):984-91. PubMed ID: 11861807
    [Abstract] [Full Text] [Related]

  • 3. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V.
    Br J Pharmacol; 2001 Oct 19; 134(4):845-52. PubMed ID: 11606325
    [Abstract] [Full Text] [Related]

  • 4. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ.
    Eur J Pharmacol; 2001 May 25; 420(2-3):123-31. PubMed ID: 11408034
    [Abstract] [Full Text] [Related]

  • 5. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR.
    Biochem Biophys Res Commun; 2001 Feb 23; 281(2):444-51. PubMed ID: 11181068
    [Abstract] [Full Text] [Related]

  • 6. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V.
    FEBS Lett; 2000 Oct 13; 483(1):52-6. PubMed ID: 11033355
    [Abstract] [Full Text] [Related]

  • 7. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
    Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, Stevenson L, Pertwee R, De Petrocellis L.
    FEBS Lett; 1998 Oct 09; 436(3):449-54. PubMed ID: 9801167
    [Abstract] [Full Text] [Related]

  • 8. Anandamide transport inhibition by the vanilloid agonist olvanil.
    Beltramo M, Piomelli D.
    Eur J Pharmacol; 1999 Jan 01; 364(1):75-8. PubMed ID: 9920187
    [Abstract] [Full Text] [Related]

  • 9. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
    Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED.
    Nature; 1999 Jul 29; 400(6743):452-7. PubMed ID: 10440374
    [Abstract] [Full Text] [Related]

  • 10. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
    Deutsch DG, Lin S, Hill WA, Morse KL, Salehani D, Arreaza G, Omeir RL, Makriyannis A.
    Biochem Biophys Res Commun; 1997 Feb 03; 231(1):217-21. PubMed ID: 9070252
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG.
    Br J Pharmacol; 2001 Feb 03; 132(3):631-40. PubMed ID: 11159715
    [Abstract] [Full Text] [Related]

  • 12. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V.
    Biochem Pharmacol; 2003 May 01; 65(9):1473-81. PubMed ID: 12732359
    [Abstract] [Full Text] [Related]

  • 13. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T, Melck D, Bobrov MYu, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V.
    Biochem J; 2000 Nov 01; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [Abstract] [Full Text] [Related]

  • 14. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.
    Brain Res Mol Brain Res; 2004 Dec 06; 132(1):87-92. PubMed ID: 15548432
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
    Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, Veldink GA, Vliegenthart JF, Bär PR, Nicolay K, Di Marzo V.
    J Neurosci; 2003 May 15; 23(10):4127-33. PubMed ID: 12764100
    [Abstract] [Full Text] [Related]

  • 16. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
    Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ.
    Br J Pharmacol; 2001 Aug 15; 133(8):1263-75. PubMed ID: 11498512
    [Abstract] [Full Text] [Related]

  • 17. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S, Khanolkar AD, Fan P, Goutopoulos A, Qin C, Papahadjis D, Makriyannis A.
    J Med Chem; 1998 Dec 31; 41(27):5353-61. PubMed ID: 9876105
    [Abstract] [Full Text] [Related]

  • 18. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
    van der Stelt M, van Kuik JA, Bari M, van Zadelhoff G, Leeflang BR, Veldink GA, Finazzi-Agrò A, Vliegenthart JF, Maccarrone M.
    J Med Chem; 2002 Aug 15; 45(17):3709-20. PubMed ID: 12166944
    [Abstract] [Full Text] [Related]

  • 19. Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide.
    Di Marzo V, Breivogel C, Bisogno T, Melck D, Patrick G, Tao Q, Szallasi A, Razdan RK, Martin BR.
    Eur J Pharmacol; 2000 Oct 20; 406(3):363-74. PubMed ID: 11040343
    [Abstract] [Full Text] [Related]

  • 20. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V.
    Endocrinology; 2000 Jan 20; 141(1):118-26. PubMed ID: 10614630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.